MLTX Smart Money
MoonLake Immunotherapeutics
1W: +15.6%
1M: +3.2%
3M: -35.1%
YTD: -0.2%
1Y: +25.3%
3Y: -78.3%
5Y: +20.3%
$11.93
+0.12 (+1.02%)
Weekly Expected Move ±10.7%
$9
$11
$12
$13
$14
Credit Risk of going bust: higher than 59% of companies Debt: 9.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.16 (down 99%), MoonLake Immunotherapeutics would be worth roughly what it owes.
Total debt $101.5M against a stock market value of $1.02B.
Distance to default 4.28 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $49.8M (short-term plus half of long-term), stock volatility 70.4%; Altman Z'' 2.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $101.5M against a stock market value of $1.02B.
Distance to default 4.28 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $49.8M (short-term plus half of long-term), stock volatility 70.4%; Altman Z'' 2.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026191
Institutions Holding
+21 vs prior
130.2%
Ownership
+17.10%
44
New
72
Increased
59
Reduced
15
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-27 | Reich Kristian | officer: chief scientific officer | S-Sale | 1,100 | $20.00 | $22K | Filing |
| 2026-07-22 | Reich Kristian | officer: chief scientific officer | S-Sale | 2,448 | $20.00 | $49K | Filing |
| 2026-07-21 | Reich Kristian | officer: chief scientific officer | S-Sale | 50,000 | $20.02 | $1.0M | Filing |
| 2026-07-20 | Reich Kristian | officer: chief scientific officer | S-Sale | 43,700 | $20.09 | $878K | Filing |
| 2026-07-15 | Reich Kristian | officer: chief scientific officer | S-Sale | 16,105 | $20.01 | $322K | Filing |
| 2026-07-10 | Santos da Silva Jorge | officer: chief executive officer | S-Sale | 68,289 | $20.02 | $1.4M | Filing |
| 2026-07-09 | Santos da Silva Jorge | officer: chief executive officer | S-Sale | 33,936 | $20.01 | $679K | Filing |
| 2026-07-01 | Santos da Silva Jorge | officer: chief executive officer | S-Sale | 47,775 | $20.03 | $957K | Filing |
| 2026-06-22 | Bodenstedt Matthias | officer: chief financial officer | S-Sale | 39,120 | $22.04 | $862K | Filing |
| 2026-06-18 | Bodenstedt Matthias | officer: chief financial officer | S-Sale | 2,794 | $19.60 | $55K | Filing |
| 2026-06-17 | Reich Kristian | officer: chief scientific officer | S-Sale | 50,000 | $19.43 | $972K | Filing |
| 2026-06-17 | Bodenstedt Matthias | officer: chief financial officer | S-Sale | 15,082 | $19.68 | $297K | Filing |
| 2026-06-16 | Reich Kristian | officer: chief scientific officer | S-Sale | 50,000 | $18.70 | $935K | Filing |
| 2026-06-15 | Reich Kristian | officer: chief scientific officer | S-Sale | 50,000 | $18.89 | $944K | Filing |
| 2026-05-11 | Bodenstedt Matthias | officer: chief financial officer | S-Sale | 13,653 | $20.02 | $273K | Filing |
| 2026-04-14 | Bodenstedt Matthias | officer: chief financial officer | S-Sale | 2,426 | $19.56 | $47K | Filing |
| 2026-04-13 | Santos da Silva Jorge | officer: chief executive officer | S-Sale | 51,873 | $18.23 | $946K | Filing |
| 2026-04-10 | Santos da Silva Jorge | officer: chief executive officer | S-Sale | 98,127 | $18.41 | $1.8M | Filing |
| 2026-04-10 | Bodenstedt Matthias | officer: chief financial officer | S-Sale | 1,925 | $19.51 | $38K | Filing |
| 2026-04-09 | Bodenstedt Matthias | officer: chief financial officer | S-Sale | 85,870 | $18.94 | $1.6M | Filing |
| 2026-01-07 | Bodenstedt Matthias | officer: chief financial officer | A-Grant/Award | 354,296 | $— | $0 | Filing |
| 2025-12-19 | Santos da Silva Jorge | officer: chief executive officer | D-Sale to Issuer | 196,316 | $— | $0 | Filing |
| 2025-12-19 | Reich Kristian | officer: chief scientific officer | D-Sale to Issuer | 35,389 | $— | $0 | Filing |
| 2025-12-19 | Santos da Silva Jorge | officer: chief executive officer | C-Conversion | 196,316 | $— | $0 | Filing |
| 2025-12-19 | Bodenstedt Matthias | officer: chief financial officer | C-Conversion | 294,473 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BVF INC/IL | 16,001,284 | $312M | — | 2026-06-30 | Filing |
| Deep Track Capital, LP | 6,999,025 | $136M | +590,162 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 3,365,507 | $66M | +974,846 | 2026-06-30 | Filing |
| Cormorant Asset Management, LP | 3,205,433 | $62M | -1,275,000 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 3,085,906 | $60M | +3,085,906 | 2026-06-30 | Filing |
| Logos Global Management LP | 2,675,000 | $52M | +1,175,000 | 2026-06-30 | Filing |
| Weiss Asset Management LP | 2,581,813 | $50M | +873,485 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 1,972,893 | $38M | +649,165 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 1,715,349 | $33M | +593,037 | 2026-06-30 | Filing |
| MPM BIOIMPACT LLC | 1,606,967 | $31M | -204,115 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 1,386,422 | $28M | +297,908 | 2026-06-30 | Filing |
| Vivo Capital, LLC | 1,400,000 | $27M | +400,000 | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 1,158,732 | $23M | -209,786 | 2026-06-30 | Filing |
| BlackRock, Inc. | 1,094,791 | $21M | +72,940 | 2026-06-30 | Filing |
| Balyasny Asset Management L.P. | 912,715 | $18M | -152,895 | 2026-06-30 | Filing |
| GREAT POINT PARTNERS LLC | 855,813 | $17M | +355,813 | 2026-06-30 | Filing |
| JANE STREET GROUP, LLC | 853,386 | $17M | +399,761 | 2026-06-30 | Filing |
| Candriam S.C.A. | 769,766 | $15M | -48,360 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 751,897 | $15M | +27,103 | 2026-06-30 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 750,777 | $15M | +680,637 | 2026-06-30 | Filing |